Pittsburgh Life Sciences Greenhouse
Pittsburgh incubator signs Nurel Therapeutics, Inc., as new tenant
Published in Cardiovascular Device Liability Week, September 19th, 2004
Nurel Therapeutics is a specialty biotechnology company developing products to treat and manage pain and peripheral nerve damage, and is expanding into vascular disease. The company's products use a proprietary drug-delivery technology derived from an "inert" herpes simplex virus that provides gene-based medicine in a safe and effective manner.
"Nurel has raised some initial funds to help develop our first product candidate, NPE1, a treatment for chronic pain that has a potential market of $1 billion in the United...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Newsweek
Newsweek issue focuses on how fat cells function - Centre Hospitalier Universitaire Nord Marseille
Abandoned sheep slaughterhouse and wind causes Q fever outbreak - Legal Issues
Judge approves revision to diet drug settlement - Mayo Clinic
Adherence to the AICR cancer prevention recommendations reduces disease risk - Nanobac Life Science, Inc.
Abstract accepted for presentation by the American Heart Association - Abbott Laboratories
FDA clears test that aids in heart attack detection - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
